- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4788
10-year publication summary
|
311
|
345
|
401
|
344
|
307
|
279
|
311
|
241
|
260
|
137
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2715 |
96 |
| Janssen Pharmaceutica N.V. | 3171 |
91 |
| Merck Sharp & Dohme LLC | 3735 |
79 |
| Boehringer Ingelheim International GmbH | 4493 |
68 |
| Bristol-myers Squibb Company | 4729 |
67 |
| F. Hoffmann-La Roche AG | 7836 |
67 |
| Novartis AG | 10263 |
64 |
| VALO Health, Inc. | 193 |
53 |
| Syngenta Crop Protection AG | 6699 |
41 |
| Merck Patent GmbH | 5725 |
37 |
| The Regents of the University of California | 20720 |
36 |
| Eli Lilly and Company | 4089 |
35 |
| Centre National de La Recherche Scientifique | 11016 |
34 |
| Allergan, Inc. | 2169 |
33 |
| Toray Industries, Inc. | 7096 |
32 |
| Mycovia Pharmaceuticals, Inc. | 40 |
32 |
| Hoffmann-La Roche Inc. | 3783 |
31 |
| ChemoCentryx, Inc. | 361 |
30 |
| BASF SE | 21303 |
26 |
| Astellas Pharma Inc. | 1043 |
26 |
| Other owners | 3810 |